Current and prospective disease-modifying therapies for amyotrophic lateral sclerosis

Author： Morren John A   Galvez-Jimenez Nestor  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.21, Iss.3, 2012-03, pp. : 297-320

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging disease-modifying therapies for the treatment of motor neuron disease/amyotropic lateral sclerosis

By Bedlack Richard S   Traynor Bryan J   Cudkowicz Merit E  

Expert Opinion on Emerging Drugs, Vol. 12, Iss. 2, 2007-05 ,pp. : 229-252

Informa Healthcare

Access to resources Recommend Favorite

Disease-Modifying Therapies for Osteoarthritis: Current Status

By Marc Fajardo   Paul E. Di Cesare  

Drugs & Aging, Vol. 22, Iss. 2, 2005-01 ,pp. : 141-161

Adis International

Access to resources Recommend Favorite

First-Line Disease-Modifying Therapies in Paediatric Multiple Sclerosis: A Comprehensive Overview

By Johnston Jessica  

Drugs, Vol. 72, Iss. 9, 2012-06 ,pp. : 1195-1211

Adis International

Access to resources Recommend Favorite

Current clinical trials in amyotrophic lateral sclerosis

By Bhatt Jaydeep M   Gordon Paul H  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 8, 2007-08 ,pp. : 1197-1207

Informa Healthcare

Access to resources Recommend Favorite

Current Therapy of Drugs in Amyotrophic Lateral Sclerosis

By  

Current Neuropharmacology, Vol. 14, Iss. 4, 2016-05 ,pp. : 314-321

Bentham Science Publishers

Access to resources Recommend Favorite